BioCryst Pharmaceuticals, Inc. (BCRX)
9.96
-0.13
(-1.29%)
USD |
NASDAQ |
Sep 04, 16:00
9.955
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Cash and Short Term Investments (Annual) : 274.95M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 274.95M |
| December 31, 2024 | 321.06M |
| December 31, 2023 | 390.79M |
| December 31, 2022 | 425.78M |
| December 31, 2021 | 510.95M |
| December 31, 2020 | 302.59M |
| December 31, 2019 | 137.78M |
| December 31, 2018 | 106.01M |
| December 31, 2017 | 117.68M |
| December 31, 2016 | 56.20M |
| December 31, 2015 | 53.18M |
| December 31, 2014 | 72.92M |
| December 31, 2013 | 38.21M |
| December 31, 2012 | 35.91M |
| December 31, 2011 | 42.34M |
| December 31, 2010 | 54.57M |
| Date | Value |
|---|---|
| December 31, 2009 | 69.59M |
| December 31, 2008 | 61.53M |
| December 31, 2007 | 50.70M |
| December 31, 2006 | 37.46M |
| December 31, 2005 | 50.26M |
| December 31, 2004 | 23.17M |
| December 31, 2003 | 20.03M |
| December 31, 2002 | 24.45M |
| December 31, 2001 | 31.99M |
| December 31, 2000 | 24.64M |
| December 31, 1999 | 23.18M |
| December 31, 1998 | 22.27M |
| December 31, 1997 | 19.48M |
| December 31, 1996 | 27.86M |
| December 31, 1995 | 11.41M |
| December 31, 1994 | 10.87M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Amgen, Inc. | 9.129B |
| Halozyme Therapeutics, Inc. | 142.82M |
| Vertex Pharmaceuticals, Inc. | 6.611B |
| Agenus, Inc. | 2.998M |
| Anika Therapeutics, Inc. | 57.48M |